Case Report: Visceral Leishmaniasis Treated with Antimonials/Paromomycin followed by Itraconazole/Miltefosine after Standard Therapy Failures in a Human Immunodeficiency Virus-Infected Patient

被引：11

作者：

Barragan, Patricia ^{[1
]}

Lopez-Velez, Rogelio ^{[2
]}

Olmo, Montserrat ^{[1
]}

Podzamczer, Daniel ^{[1
]}

机构：

[1] Hosp Univ Bellvitge, Infect Dis Serv, Barcelona 08907, Spain

[2] Hosp Ramon & Cajal, Dept Infect Dis, E-28034 Madrid, Spain

来源：

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2010年 / 83卷 / 01期

关键词：

PLUS SODIUM STIBOGLUCONATE; HIV-INFECTION; KALA-AZAR; AMINOSIDINE; PAROMOMYCIN; TRIAL; INDIA; BIHAR; AIDS;

D O I：

10.4269/ajtmh.2010.09-0594

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Visceral leishmaniasis is an opportunistic infection that affects human immunodeficiency virus infected persons in leishmaniasis-endemic areas. The standard treatment may not be effective and relapses are common. We report the case of a human immunodeficiency virus-1-infected patient who had several relapses of visceral leishmaniasis after treatment with standard therapies and responded to a combined therapy.

引用

页码：10 / 12

页数：3

共 20 条

[1] The relationship between leishmaniasis and AIDS:: the second 10 years [J].

Alvar, Jorge ;

Aparicio, Pilar ;

Aseffa, Abraham ;

Den Boer, Margriet ;

Canavate, Carmen ;

Dedet, Jean-Pierre ;

Gradoni, Luigi ;

Ter Horst, Rachel ;

Lopez-Velez, Rogelio ;

Moreno, Javier .

CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (02) :334-+

[2] Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients [J].

Angarano G. ;

Maggi P. ;

Coppola S.L. ;

Cavaliere R.L. .

European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 (5) :365-367

[3] Multiple digestive involvement by visceral leishmaniasis in a patient with immunodeficiency infection: Improved course with itraconazole. [J].

Bechade, D ;

Seurat, L ;

Discamps, G ;

Taniere, PH ;

DuBourguet, F .

REVUE DE MEDECINE INTERNE, 1996, 17 (03) :234-237

[4] TREATMENT OF VISCERAL LEISHMANIASIS IN KENYA BY AMINOSIDINE ALONE OR COMBINED WITH SODIUM STIBOGLUCONATE [J].

CHUNGE, CN ;

OWATE, J ;

PAMBA, HO ;

DONNO, L .

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1990, 84 (02) :221-225

[5] Practical guide for the treatment of leishmaniasis [J].

Davidson, RN .

DRUGS, 1998, 56 (06) :1009-1018

[6] Paromomycin [J].

Davidson, Robert N. ;

den Boer, Margriet ;

Ritmeijer, Koert .

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2009, 103 (07) :653-660

[7] Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy [J].

de la Rosa, R ;

Pineda, JA ;

Delgado, J ;

Macías, J ;

Morillas, F ;

Mira, JA ;

Sánchez-Quijano, A ;

Leal, M ;

Lissen, E .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :762-767

[8] Randomised controlled trial of aminosidine (paromomycin) υ sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India [J].

Jha, TK ;

Olliaro, P ;

Thakur, CPN ;

Kanyok, TP ;

Singhania, BL ;

Singh, IJ ;

Singh, NKP ;

Akhoury, S ;

Jha, S .

BRITISH MEDICAL JOURNAL, 1998, 316 (7139) :1200-1205

[9] MAINTENANCE ITRACONAZOLE FOR VISCERAL LEISHMANIASIS IN HIV-INFECTION [J].

LAFEUILLADE, A ;

CHAFFANJON, P ;

DELBEKE, E ;

QUILICHINI, R .

AMERICAN JOURNAL OF MEDICINE, 1992, 92 (04) :449-449

[10] Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration [J].

Manfredi, Roberto ;

Marinacci, Ginevra ;

Calza, Leonardo ;

Passarini, Beatrice .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (06) :590-592

← 1 2 →